Trial Profile
Morning to evening ratio in total dose of twice-daily biphasic insulin analog in achieving glucose control in patients with poorly controlled type 2 diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Dec 2012 New trial record